$BIND Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in DNIB UNWIND, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in DNIB UNWIND, INC.. Get notifications about new insider transactions in DNIB UNWIND, INC. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 30 2016 | BIND | DNIB UNWIND, INC. | Rowinsky Eric K | Director | Option Exercise | M | 0.44 | 15,000 | 6,600 | 0 | |
Aug 30 2016 | BIND | DNIB UNWIND, INC. | Rowinsky Eric K | Director | Buy | M | 0.44 | 15,000 | 6,600 | 15,000 | 0 to 15 K |
Aug 30 2016 | BIND | DNIB UNWIND, INC. | HUTT PETER BARTON | Director | Option Exercise | M | 0.44 | 15,000 | 6,600 | 0 | |
Aug 30 2016 | BIND | DNIB UNWIND, INC. | HUTT PETER BARTON | Director | Buy | M | 0.44 | 15,000 | 6,600 | 15,000 | 0 to 15 K |
Aug 30 2016 | BIND | DNIB UNWIND, INC. | TZIANABOS ARTHUR | Director | Option Exercise | M | 0.44 | 15,000 | 6,600 | 0 | |
Aug 30 2016 | BIND | DNIB UNWIND, INC. | TZIANABOS ARTHUR | Director | Buy | M | 0.44 | 15,000 | 6,600 | 15,000 | 0 to 15 K |
Aug 30 2016 | BIND | DNIB UNWIND, INC. | Rowland Charles A Jr | Director | Option Exercise | M | 0.44 | 15,000 | 6,600 | 0 | |
Aug 30 2016 | BIND | DNIB UNWIND, INC. | Rowland Charles A Jr | Director | Buy | M | 0.44 | 15,000 | 6,600 | 15,000 | 0 to 15 K |
Aug 30 2016 | BIND | DNIB UNWIND, INC. | LYNCH DANIEL | Director | Option Exercise | M | 0.44 | 20,000 | 8,800 | 0 | |
Aug 30 2016 | BIND | DNIB UNWIND, INC. | LYNCH DANIEL | Director | Buy | M | 0.44 | 20,000 | 8,800 | 20,000 | 0 to 20 K |
Aug 30 2016 | BIND | DNIB UNWIND, INC. | LANGER ROBERT | Director | Option Exercise | M | 0.44 | 15,000 | 6,600 | 0 | |
Aug 30 2016 | BIND | DNIB UNWIND, INC. | LANGER ROBERT | Director | Buy | M | 0.44 | 15,000 | 6,600 | 738,424 | 723.4 K to 738.4 K (+2.07 %) |
Jun 22 2016 | BIND | BIND Therapeutics, ... | TZIANABOS ARTHUR | Director | Option Exercise | A | 0.44 | 15,000 | 6,600 | 15,000 | |
Jun 22 2016 | BIND | BIND Therapeutics, ... | Rowland Charles A Jr | Director | Option Exercise | A | 0.44 | 15,000 | 6,600 | 15,000 | |
Jun 22 2016 | BIND | BIND Therapeutics, ... | Rowinsky Eric K | Director | Option Exercise | A | 0.44 | 15,000 | 6,600 | 15,000 | |
Jun 22 2016 | BIND | BIND Therapeutics, ... | LYNCH DANIEL | Director | Option Exercise | A | 0.44 | 20,000 | 8,800 | 20,000 | |
Jun 22 2016 | BIND | BIND Therapeutics, ... | LANGER ROBERT | Director | Option Exercise | A | 0.44 | 15,000 | 6,600 | 15,000 | |
Jun 22 2016 | BIND | BIND Therapeutics, ... | HUTT PETER BARTON | Director | Option Exercise | A | 0.44 | 15,000 | 6,600 | 15,000 | |
Dec 16 2015 | BIND | BIND Therapeutics, ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Option Exercise | A | 2.38 | 200,000 | 476,000 | 200,000 | |
Nov 03 2015 | BIND | BIND Therapeutics, ... | TROIANO GREGORY | SENIOR VICE PRESIDE ... | Option Exercise | A | 4.36 | 8,000 | 34,880 | 8,000 | |
Oct 14 2015 | BIND | BIND Therapeutics, ... | TZIANABOS ARTHUR | Director | Option Exercise | A | 4.52 | 25,000 | 113,000 | 25,000 | |
Jun 23 2015 | BIND | BIND Therapeutics, ... | Hirsch Andrew | PRESIDENT & CEO | Option Exercise | A | 5.86 | 20,000 | 117,200 | 20,000 | |
Jun 10 2015 | BIND | BIND Therapeutics, ... | SCHULMAN AMY W | Director | Option Exercise | A | 5.87 | 15,000 | 88,050 | 15,000 | |
Jun 10 2015 | BIND | BIND Therapeutics, ... | Rowland Charles A Jr | Director | Option Exercise | A | 5.87 | 15,000 | 88,050 | 15,000 | |
Jun 10 2015 | BIND | BIND Therapeutics, ... | Rowinsky Eric K | Director | Option Exercise | A | 5.87 | 15,000 | 88,050 | 15,000 | |
Jun 10 2015 | BIND | BIND Therapeutics, ... | Nashat Amir | Director | Option Exercise | A | 5.87 | 15,000 | 88,050 | 15,000 | |
Jun 10 2015 | BIND | BIND Therapeutics, ... | LANGER ROBERT | Director | Option Exercise | A | 5.87 | 15,000 | 88,050 | 15,000 | |
Jun 10 2015 | BIND | BIND Therapeutics, ... | HUTT PETER BARTON | Director | Option Exercise | A | 5.87 | 15,000 | 88,050 | 15,000 | |
Jun 10 2015 | BIND | BIND Therapeutics, ... | LYNCH DANIEL | Director | Option Exercise | A | 5.87 | 20,000 | 117,400 | 20,000 | |
Mar 10 2015 | BIND | BIND Therapeutics, ... | Youssoufian Hagop | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 5.96 | 30,000 | 178,800 | 30,000 | |
Mar 10 2015 | BIND | BIND Therapeutics, ... | Lindblom Christopher M | SVP, FINANCE & ADMI ... | Option Exercise | A | 5.96 | 45,000 | 268,200 | 45,000 | |
Mar 10 2015 | BIND | BIND Therapeutics, ... | Koerwer Dan | CHIEF BUSINESS OFFI ... | Option Exercise | A | 5.96 | 85,000 | 506,600 | 85,000 | |
Mar 10 2015 | BIND | BIND Therapeutics, ... | Hirsch Andrew | PRESIDENT & CEO | Option Exercise | A | 5.96 | 140,000 | 834,400 | 140,000 | |
Nov 04 2014 | BIND | BIND Therapeutics, ... | Youssoufian Hagop | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 8.05 | 175,000 | 1,408,750 | 175,000 | |
Sep 12 2014 | BIND | BIND Therapeutics, ... | Minick Scott | President & CEO | Buy | J | 0.00 | 161 | 0 | 341,160 | 341 K to 341.2 K (+0.05 %) |
Sep 12 2014 | BIND | BIND Therapeutics, ... | Minick Scott | President & CEO | Gift | G | 0.00 | 1,100 | 0 | 250,635 | 251.7 K to 250.6 K (-0.44 %) |
Sep 12 2014 | BIND | BIND Therapeutics, ... | Minick Scott | President & CEO | Buy | J | 0.00 | 161 | 0 | 251,735 | 251.6 K to 251.7 K (+0.06 %) |
Sep 04 2014 | BIND | BIND Therapeutics, ... | SCHULMAN AMY W | Director | Option Exercise | A | 10.19 | 25,000 | 254,750 | 25,000 | |
Sep 04 2014 | BIND | BIND Therapeutics, ... | Rowinsky Eric K | Director | Option Exercise | A | 10.19 | 25,000 | 254,750 | 25,000 | |
Jul 09 2014 | BIND | BIND Therapeutics, ... | Minick Scott | President & CEO | Buy | J | 0.00 | 160 | 0 | 251,574 | 251.4 K to 251.6 K (+0.06 %) |
May 29 2014 | BIND | BIND Therapeutics, ... | Nashat Amir | Director | Option Exercise | A | 8.73 | 15,000 | 130,950 | 15,000 | |
May 29 2014 | BIND | BIND Therapeutics, ... | LYNCH DANIEL | Director | Option Exercise | A | 8.73 | 20,000 | 174,600 | 20,000 | |
May 29 2014 | BIND | BIND Therapeutics, ... | LANGER ROBERT | Director | Option Exercise | A | 8.73 | 15,000 | 130,950 | 15,000 | |
May 29 2014 | BIND | BIND Therapeutics, ... | HUTT PETER BARTON | Director | Option Exercise | A | 8.73 | 15,000 | 130,950 | 15,000 | |
May 29 2014 | BIND | BIND Therapeutics, ... | Rowland Charles A Jr | Director | Option Exercise | A | 8.73 | 25,000 | 218,250 | 25,000 | |
Mar 13 2014 | BIND | BIND Therapeutics, ... | LYNCH DANIEL | Director | Option Exercise | A | 12.81 | 20,000 | 256,200 | 20,000 | |
Mar 13 2014 | BIND | BIND Therapeutics, ... | Minick Scott | President & CEO | Option Exercise | A | 12.81 | 80,000 | 1,024,800 | 80,000 | |
Mar 13 2014 | BIND | BIND Therapeutics, ... | Koerwer Dan | SVP, BD and Commerc ... | Option Exercise | A | 12.81 | 40,000 | 512,400 | 40,000 | |
Mar 13 2014 | BIND | BIND Therapeutics, ... | Hrkach Jeff | Chief Technology Of ... | Option Exercise | A | 12.81 | 40,000 | 512,400 | 40,000 | |
Mar 13 2014 | BIND | BIND Therapeutics, ... | Hirsch Andrew | COO and CFO | Option Exercise | A | 12.81 | 45,000 | 576,450 | 45,000 | |
Jan 15 2014 | BIND | BIND Therapeutics, ... | Berk Gregory | Chief Medical Offic ... | Option Exercise | D | 2.52 | 64,189 | 161,756 | 47,391 | |
Jan 15 2014 | BIND | BIND Therapeutics, ... | Berk Gregory | Chief Medical Offic ... | Option Exercise | D | 2.52 | 4,453 | 11,222 | 3,180 | |
Jan 15 2014 | BIND | BIND Therapeutics, ... | Berk Gregory | Chief Medical Offic ... | Option Exercise | D | 2.78 | 4,967 | 13,808 | 0 | |
Jan 15 2014 | BIND | BIND Therapeutics, ... | Berk Gregory | Chief Medical Offic ... | Option Exercise | A | 2.78 | 4,967 | 13,808 | 4,967 | |
Jan 15 2014 | BIND | BIND Therapeutics, ... | Berk Gregory | Chief Medical Offic ... | Option Exercise | A | 2.78 | 4,967 | 13,808 | 9,934 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 964,798 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 390,170 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 487,780 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 1,900,000 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 1,476,960 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Buy | P | 15.00 | 26,000 | 390,000 | 2,018,253 | 2 M to 2 M (+1.31 %) |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 1,992,253 | 0 | 1,992,253 | 0 to 2 M |
Sep 27 2013 | BIND | BIND Therapeutics, ... | LYNCH DANIEL | Chairman | Option Exercise | A | 9.36 | 134,439 | 1,258,349 | 134,439 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | LYNCH DANIEL | Chairman | Option Exercise | A | 2.52 | 3,057 | 7,704 | 3,057 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | LYNCH DANIEL | Chairman | Option Exercise | A | 2.52 | 69,880 | 176,098 | 69,880 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Minick Scott | President and CEO | Option Exercise | A | 2.52 | 34,351 | 86,565 | 34,351 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Minick Scott | President and CEO | Option Exercise | A | 2.52 | 144,866 | 365,062 | 144,866 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Minick Scott | President and CEO | Option Exercise | A | 2.52 | 25,556 | 64,401 | 25,556 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Option Exercise | C | 0.00 | 407,060 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Option Exercise | C | 0.00 | 333,288 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Option Exercise | C | 0.00 | 416,667 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Option Exercise | C | 0.00 | 1,900,000 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Option Exercise | C | 0.00 | 984,640 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Buy | P | 15.00 | 20,000 | 300,000 | 1,562,616 | 1.5 M to 1.6 M (+1.30 %) |
Sep 27 2013 | BIND | BIND Therapeutics, ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Buy | C | 0.00 | 1,542,616 | 0 | 1,542,616 | 0 to 1.5 M |
Sep 27 2013 | BIND | BIND Therapeutics, ... | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 407,060 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 333,288 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 416,667 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 1,900,000 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 984,640 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | AFEYAN NOUBAR | Director | Buy | P | 15.00 | 20,000 | 300,000 | 1,562,616 | 1.5 M to 1.6 M (+1.30 %) |
Sep 27 2013 | BIND | BIND Therapeutics, ... | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 1,542,616 | 0 | 1,542,616 | 0 to 1.5 M |
Sep 27 2013 | BIND | BIND Therapeutics, ... | RUSNANO | 10% Owner | Option Exercise | C | 0.00 | 2,759,624 | 0 | 0 | |
Sep 27 2013 | BIND | BIND Therapeutics, ... | RUSNANO | 10% Owner | Buy | P | 15.00 | 120,000 | 1,800,000 | 1,491,357 | 1.4 M to 1.5 M (+8.75 %) |
Sep 27 2013 | BIND | BIND Therapeutics, ... | RUSNANO | 10% Owner | Buy | C | 0.00 | 1,053,291 | 0 | 1,371,357 | 318.1 K to 1.4 M (+331.15 %) |
Page: 1